NASDAQ$UFPT
UFP Technologies Inc · Q4 2019 earnings
Q4 2019 earnings · · Investor relations
Briefing
Reported record results driven by growth in medical sales and improved operating efficiency.
UFP Technologies reported a slight decrease in sales but an increase in net income for Q4 2019 compared to Q4 2018. Full year results showed significant growth in revenue, operating income, and net income, driven by increased medical sales and improved operating efficiency.
- Net income for Q4 2019 was $5.8 million, or $0.77 per diluted share, compared to $4.4 million, or $0.59 per diluted share, in Q4 2018.
- Sales for Q4 2019 were $50.3 million, slightly down from $50.7 million in Q4 2018.
- Medical sales increased 16.9% to $128.9 million, representing 65% of the total business.
- The company paid off the $56 million borrowed to purchase Dielectrics.
Headline financials
Revenue & EPS history
UFP Technologies · Revenue · Quarterly
$50.3M
Revenue by segment
UFP Technologies · $129M total across 1 segment · Q4 2019
- Medical$129M—100.0%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2019
+2.7%
Avg return
Earnings day
+3.1%
Avg return
5 days after
+5.5%
Avg return
30 days after
66%
43 / 65 earnings
Positive
+24.0%
Q1 2024
Best reaction
-11.6%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +4.2% | -1.0% | +1.1% | |
| Q4 2025 | +0.3% | -15.1% | -21.2% | |
| Q3 2025 | +12.2% | +13.6% | +8.6% | |
| Q1 2025 | +11.2% | +19.8% | +23.6% | |
| Q4 2024 | +9.4% | -5.5% | -15.7% | |
| Q3 2024 | +23.8% | +24.2% | +4.5% | |
| Q2 2024 | +2.8% | -5.4% | +7.7% | |
| Q1 2024 | +24.0% | +24.5% | +26.4% | |
| Q4 2023 | +10.5% | +11.3% | +26.2% | |
| Q3 2023 | -11.6% | -8.0% | +6.9% | |
| Q2 2023 | -5.5% | -6.3% | -9.7% | |
| Q1 2023 | +5.8% | +2.0% | +13.9% | |
| Q4 2022 | +10.8% | +2.9% | +16.5% | |
| Q3 2022 | +16.4% | +21.5% | +31.6% | |
| Q2 2022 | +11.2% | +11.1% | +14.1% | |
| Q1 2022 | +5.9% | +3.1% | +14.2% | |
| Q4 2021 | -1.0% | -11.1% | +1.3% | |
| Q3 2021 | +4.1% | +6.8% | +7.6% | |
| Q2 2021 | +9.6% | +12.5% | +14.8% | |
| Q1 2021 | +8.1% | +8.8% | +15.4% | |
| Q4 2020 | +1.4% | -7.8% | -0.7% | |
| Q3 2020 | +13.2% | +18.9% | +25.0% | |
| Q2 2020 | +3.7% | +2.5% | -6.4% | |
| Q1 2020 | +1.3% | +7.1% | +10.0% | |
| Q4 2019 | +3.0% | -4.2% | -28.6% | |
| Q3 2019 | -0.2% | +1.3% | +7.7% | |
| Q2 2019 | +2.6% | -1.4% | -2.2% | |
| Q1 2019 | +2.8% | +3.6% | +5.0% | |
| Q4 2018 | -1.4% | -0.2% | +8.6% | |
| Q3 2018 | -0.8% | -1.8% | +5.1% | |
| Q2 2018 | +2.7% | +10.2% | +7.6% | |
| Q1 2018 | -0.6% | -3.2% | -6.2% | |
| Q4 2017 | -3.3% | -1.4% | +3.7% | |
| Q3 2017 | -10.1% | -11.1% | -9.0% | |
| Q2 2017 | -3.3% | -3.8% | -8.0% | |
| Q1 2017 | +1.7% | +1.1% | +4.9% | |
| Q4 2016 | +0.4% | +1.2% | +5.7% | |
| Q3 2016 | -4.6% | -3.5% | -4.6% | |
| Q2 2016 | +3.3% | +2.9% | +7.5% | |
| Q1 2016 | +1.3% | — | — | |
| Q4 2015 | +5.6% | — | — | |
| Q3 2015 | -0.6% | — | — | |
| Q2 2015 | +12.7% | — | — | |
| Q1 2015 | -2.7% | — | — | |
| Q4 2014 | -7.5% | — | — | |
| Q3 2014 | +0.9% | — | — | |
| Q2 2014 | -2.1% | — | — | |
| Q1 2014 | -1.2% | — | — | |
| Q4 2013 | +0.1% | — | — | |
| Q3 2013 | -0.9% | — | — | |
| Q2 2013 | +1.4% | — | — | |
| Q1 2013 | -3.4% | — | — | |
| Q4 2012 | -0.6% | — | — | |
| Q3 2012 | -2.5% | — | — | |
| Q2 2012 | +1.3% | — | — | |
| Q1 2011 | +2.5% | — | — | |
| Q1 2012 | +0.6% | — | — | |
| Q4 2009 | -3.0% | — | — | |
| Q4 2011 | -3.0% | — | — | |
| Q3 2010 | +2.6% | — | — | |
| Q3 2011 | +2.6% | — | — | |
| Q4 2010 | +1.3% | — | — | |
| Q2 2010 | +1.3% | — | — | |
| Q2 2011 | +1.3% | — | — | |
| Q1 2010 | +0.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro